Roycederm is not FDA-approved. The FDA has explicitly stated that this product “has not been found by FDA to be safe and effective,” and its labeling has not been approved by the agency. That doesn’t necessarily mean the product is dangerous, but it does mean no independent regulatory body has verified its safety claims. If you’re considering Roycederm for seborrheic dermatitis or psoriasis, here’s what you should know about what’s actually in it and what the risks look like.
What the FDA Listing Actually Says
Roycederm products appear in the National Library of Medicine’s DailyMed database, which is where drug manufacturers submit their labeling information. But being listed in DailyMed is not the same as being FDA-approved. Each Roycederm product listing carries the marketing status “unapproved drug other,” along with a disclaimer that the FDA has not evaluated it for safety or effectiveness. The product’s NDC codes (the unique identifiers assigned to drug products) are listed as inactivated, which can indicate the product has been discontinued or its registration is no longer current.
The company behind Roycederm is privately held and headquartered at a registered agent address in Sheridan, Wyoming, a location commonly used by small businesses for incorporation purposes rather than as a physical manufacturing facility. No public information is available about where or how the products are manufactured, or what quality control standards are in place.
What’s in Roycederm Cream
The seborrheic dermatitis and psoriasis cream contains one recognized active ingredient: 3% salicylic acid. This is a well-established keratolytic, meaning it helps soften and shed the thick, flaky skin patches common in psoriasis and seborrheic dermatitis. At 3%, it falls within the standard over-the-counter range (typically 1.8% to 3%) that the FDA recognizes for treating these conditions. Salicylic acid itself has a long safety track record when used topically at these concentrations.
The rest of the formula is where things get less straightforward. The cream contains several traditional Chinese herbal extracts:
- Sophora flavescens root, used in traditional medicine for inflammatory skin conditions
- Dictamnus dasycarpus root bark, another traditional anti-itch ingredient
- Cnidium monnieri fruit oil, commonly found in Chinese topical preparations
- Phellodendron amurense bark, traditionally used for its antimicrobial properties
- Smilax glabra, sometimes called Chinese sarsaparilla
- Bassia scoparia fruit
- Artemisia vulgaris oil, derived from mugwort
These botanical ingredients have histories in traditional Chinese medicine, but none have been through the rigorous clinical testing the FDA requires to confirm they’re safe and effective for treating skin conditions. Some of them, particularly mugwort oil, are known to cause allergic contact dermatitis in sensitive individuals, which is ironic for a product meant to treat skin irritation.
Roycederm Sulfur Soap
Roycederm also makes a sulfur soap containing 10% sulfur as its active ingredient, with 0.25% salicylic acid listed as an inactive ingredient. Sulfur at 10% is within the range used in OTC acne and seborrheic dermatitis products, and it has established antifungal and keratolytic properties. Like the cream, however, the soap carries the same “unapproved drug” status. The sulfur itself is a familiar ingredient, but the overall formulation hasn’t been evaluated.
Known Warnings and Restrictions
The product labeling includes several precautions. Roycederm cream should not be used on pregnant women or children under 12 unless directed by a doctor. You should avoid getting it in your eyes. The label also advises checking whether you’re allergic to any ingredients before use, which is worth taking seriously given the number of botanical extracts in the formula.
If your condition worsens or doesn’t improve with regular use, the label instructs you to stop and talk to a doctor. No specific side effect rates or adverse reaction data are published for Roycederm, which itself is a concern. FDA-approved products are required to disclose this information based on clinical trial data. Without that data, you’re relying on the manufacturer’s word and your own experience.
Why the “Unapproved” Status Matters
Plenty of over-the-counter products use ingredients the FDA considers “generally recognized as safe and effective,” like salicylic acid or sulfur, without needing individual product approval. But Roycederm’s formulation goes beyond these standard ingredients by incorporating multiple herbal extracts that haven’t been evaluated through the FDA’s OTC drug monograph system. That’s likely why the products carry the “unapproved drug other” designation rather than being marketed under an existing monograph.
The practical risk here is twofold. First, without FDA oversight, there’s no independent verification that the product contains exactly what the label says, in the concentrations listed, free from contaminants. Second, the herbal ingredients haven’t been tested for interactions with other topical treatments you might be using, or for long-term safety on compromised skin. People with seborrheic dermatitis and psoriasis already have disrupted skin barriers, which means topical ingredients absorb more readily and irritation risk increases.
If you’re looking for OTC treatment for seborrheic dermatitis or psoriasis, products containing salicylic acid, coal tar, zinc pyrithione, or selenium sulfide that are marketed under established FDA monographs offer a more predictable safety profile. These ingredients have decades of clinical data behind them, and products sold under the monograph system must follow specific manufacturing standards.